Open AccessAbstract 2153: Development of a novel MEK mutation driven drug resistant melanoma model by CRISPR/Cas9 technology
Author(s) -
Lysa-Anne Volpe,
Metewo Selase Enuameh,
Luping Chen,
Elizabeth L. Turner,
John Foulke,
Fang Tian
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-2153
Subject(s) - crispr , mutation , sanger sequencing , melanoma , biology , cancer research , cas9 , mapk/erk pathway , mek inhibitor , carcinogenesis , plasmid , cancer , gene , kinase , genetics